Aleafia Health Inc. AH ALEAF has repaid a $25 million debt to Emblem Corp. in cash.
Emblem Corp. issued an 8% unsecured convertible debt on Feb. 2, 2018. The Toronto-based company acquired it on March 14, 2019.
“Our team is excited to see continued cannabis sales growth in 2021, driven by new products launched late last year,” said Aleafia Health CEO Geoffrey Benic.
“The adult-use, medical and international cannabis markets are the pillars of our 2021 growth strategy, and we look forward to capitalizing on this global opportunity through the continued expansion of our cannabis product portfolio,” Benic added.
The fourth quarter was Aleafia's best quarter to date for cannabis sales. Over the last month, the vertically integrated cannabis company boosted its global distribution network by agreeing to supply Europe-based pharmaceutical producer and distributor Apipharm Veletrgovina d.o.o. with cannabis flower under the three-year agreement.
The company also teamed up with Canada’s largest private trade union, Unifor, to “support union members, retirees and their eligible dependents who receive medical cannabis insurance coverage through Unifor’s collective bargaining agreements.”
Aleafia intends to support members of the union as well as their families by utilizing its network of medical cannabis clinics and products.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Top Cannabis Event In New Jersey
Join the Benzinga Cannabis Market Spotlight in New Jersey on June 17th! Grow your business, raise money and capitalize on the booming NJ recreational market. Don’t miss this must-attend event in New Brunswick. Secure your tickets now. Very few spots are left. Use the code "JAVIER20" for 20% off!